The Tampa Bay Rays have suffered a significant blow to their starting rotation as right-hander Ryan Pepiot has been transferred to the 60-day injured list. The move comes after Pepiot received an injection in his hip that will push back his return to the majors by approximately six weeks, marking a substantial setback for the pitcher who was initially expected to miss minimal time.
From Short-Term Setback to Extended Absence
Pepiot was originally placed on the 15-day injured list with right hip inflammation just before the start of the 2026 season. Manager Kevin Cash indicated that Pepiot had managed the injury throughout spring training, and the team initially hoped for a quick return. Cash said he did not anticipate Pepiot being sidelined long, suggesting it could be a minimum stay on the IL.
However, the situation has deteriorated. The recent injection Pepiot received to address his hip discomfort has extended his timeline significantly, necessitating the move to the 60-day injured list. This means the earliest Pepiot could return to major league action would be in mid-to-late June, assuming no further complications arise during his recovery.
Impact on the Rays Rotation
The extended absence of Pepiot creates a substantial void in Tampa Bay's starting rotation. The 28-year-old right-hander made a career-high 31 starts for the Rays in 2025, finishing with a 3.86 ERA over 167.2 innings. Despite allowing 26 home runs last season, Pepiot remained one of the team's most reliable starters and secured a $3.025 million contract to avoid arbitration this offseason.
Joe Boyle was recalled from Triple-A Durham to slide into Pepiot's rotation slot when the injury was first announced. The Rays will need to continue relying on depth options to fill the gap left by Pepiot's extended absence as they navigate the early portion of the 2026 season.
Pepiot's Previous Injury History
This isn't the first time Pepiot has dealt with injury setbacks during his career. While he had a relatively healthy 2024 season with the Rays, showcasing strong performance down the stretch, he has experienced various ailments throughout his professional career. The right-hander will now focus on allowing the injection to take effect and working through a rehabilitation program to return to full strength.
Looking Ahead
The Rays organization will monitor Pepiot's progress closely over the coming weeks. The six-week timeline suggests that once the inflammation subsides following the injection, Pepiot will need to build back up his arm strength through bullpen sessions, live batting practice, and potentially minor league rehabilitation starts before rejoining the major league roster.
For a Tampa Bay team that has built its success on pitching depth and development, losing a key rotation piece for an extended period presents a challenge. The organization's ability to navigate this absence will be tested as they look to remain competitive in the American League East. Fans and fantasy baseball managers alike will be hoping for a smooth recovery process that allows Pepiot to return to the mound at full strength later this summer.
Sources & Original Reporting
